Characterization of the Melanoma-Specific Immune Response

Description

The aim of this study is to study T-cells. Blood will be collected and the samples will be used to generate T cell clones. Two separate blood draws will be required at the maximum.

Conditions

Melanoma

Talk to us

Study Overview

On this page

Study Details

Study overview

The aim of this study is to study T-cells. Blood will be collected and the samples will be used to generate T cell clones. Two separate blood draws will be required at the maximum.

Characterization of the Melanoma-Specific Immune Response

Characterization of the Melanoma-Specific Immune Response

Condition
Melanoma
Intervention / Treatment

-

Contacts and Locations

Sacramento

University of California, Davis Department of Dermatology, Sacramento, California, United States, 95816

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

For general information about clinical research, read Learn About Studies.

Eligibility Criteria

  • * Biopsy diagnosis of malignant melanoma
  • * Have had a biopsy diagnosis of malignant melanoma in the past
  • * Patients taking immunosuppressive medications

Ages Eligible for Study

18 Years to 85 Years

Sexes Eligible for Study

ALL

Accepts Healthy Volunteers

Yes

Collaborators and Investigators

University of California, Davis,

Emanual Maverakis, M.D., PRINCIPAL_INVESTIGATOR, University of California, Davis

Study Record Dates

2024-08